Mycophenolate as Primary Treatment for Immune Checkpoint Inhibitor Induced Acute Kidney Injury in a Patient with Concurrent Immunotherapy-Associated Diabetes: A Case Report.
Jessel S, Austin M, Kluger HM. Mycophenolate as Primary Treatment for Immune Checkpoint Inhibitor Induced Acute Kidney Injury in a Patient with Concurrent Immunotherapy-Associated Diabetes: A Case Report. Clinical Oncology Case Reports 2021, 4 PMID: 33763663, PMCID: PMC7985664.Peer-Reviewed Original ResearchAcute kidney injuryImmune checkpoint inhibitorsKidney injuryCheckpoint inhibitorsT cellsImmune-related adverse eventsCycles of nivolumabEffective frontline therapyAggressive fluid resuscitationSteroid-sparing agentRegulatory T cellsInitiation of insulinT cell responsesCytotoxic T cellsMycophenolate mofetilAdverse eventsFrontline therapyRenal functionComplete responseFluid resuscitationKidney functionCase reportMetastatic melanomaPrimary treatmentTumor types